It’s an ordinarily overcast day, but the artificial lights of the lab radiate a crude brightness for Professor Stephen Taylor and his team. The room is bustling and busy. Scientific equipment and bottles filled with striking liquids are spread across the work benches, and there’s a machine in the corner that seems to be sucking […]
Expanded medication assistance program increases access to cancer medications
The Medical Assistance Program at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) has helped more than 30,000 patients gain access to vital medications valued at more than $500 million, and a new program expansion will further increase access to vital cancer therapies for patients […]
Researchers develop ‘multitasking’ AI tool to extract cancer data in record time
As the second-leading cause of death in the United States, cancer is a public health crisis that afflicts nearly one in two people during their lifetime. Cancer is also an oppressively complex disease. Hundreds of cancer types affecting more than 70 organs have been recorded in the nation’s cancer registries—databases of information about individual cancer […]
Husband left unable to have sex after penis gets savaged by flesh-eating bug
The wife of a cancer patient who was left unable to have sex after losing part of his penis to a flesh-eating superbug claims their relationship is “stronger than ever”. Sue, 61, and Andrew Lane, 65, from Essex, were handed a six-figure payout after the hospital failed to remove his prostate gland in March 2013. […]
Most innovative cancer drugs facing delays in reaching patients
Cancer patients have had to wait longer for innovative new cancer drugs than for more conventional treatments, suggesting the most exciting new therapies have not been successfully fast tracked, a new analysis reports. The researchers found that the higher the level of innovation of a cancer drug, the longer it was taking to pass through […]
Updated guidelines issued for ER, PgR testing in breast cancer
(HealthDay)—In an American Society of Clinical Oncology/College of American Pathologists updated guideline, published online Jan. 13 in the Archives of Pathology & Laboratory Medicine and the Journal of Clinical Oncology, recommendations are presented for estrogen and progesterone receptor (ER/PgR) testing in breast cancer. Kimberly H. Allison, M.D., from the Stanford University School of Medicine in […]